a b s t r a c t
We compared the follow-up data on loop diuretic use and renal function, as assessed by serum creatinine levels, and the estimated glomerular filtration rate (eGFR), of two groups of consecutive ambulatory HF patients: 1) the clinically-guided group, in which management was clinically driven based on the institutional protocol of the HF Unit of the Cardiovascular and Thoracic Department of Pisa (standard of care) and 2) the echo and B-type natriuretic peptide (BNP) guided group (patients conforming to the protocol of the Network Labs Ultrasound (NEBULA) in HF Study Group: Pisa, Perugia, Pavia; Verona, Auckland, and Veruno), in which therapy was delivered according to the serial assessment of BNP and echocardiography. Patients whose follow-up was based on standard of care had a significant higher prevalence of worsening renal function, that was likely related to higher diuretic dosages, whilst, a better management of renal function was observed in the echo-BNP-guided group. The data Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dib is related to "Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients" (A. Simioniuc 
Data
Transthoracic two-dimensional and Doppler echocardiographic examination was carried out with commercial equipments with 2nd-harmonic imaging. BNP concentrations were processed by Alere Triage BNP Test for Beckman Coulter Immunoassay Systems (Alere San Diego Inc., San Diego, CA, USA), a two-site immunoenzymatic (sandwich) quantitative assay. The eGFR was calculated from the simplified formula derived from the Modification of Diet in Renal Disease study. Supplementary Table 1 shows the characteristics of the study groups. Supplementary Table 2 describes the data on diuretic use (furosemide dose) and the changes in renal function [1] .
Experimental design, materials and methods
This was a retrospective, multicenter, observational study that involved 1137 consecutive outpatients (total cohort). In a group of 570 patients with HF (mean ejection fraction [EF] ¼30%), management was guided according to the presence of echo signs of elevated left ventricular filling pressure and serum BNP levels, while in the other (n¼ 567, mean EF¼ 33%), management was based on clinical judgment. In the latter group, echocardiography was repeated only in the case of changes in clinical status.
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